№ lp_1_2_63186
File format: docx
Character count: 5734
File size: 71 KB
This document outlines the procedures for collecting, processing, and analyzing clinical specimens in the investigation of genital infections in paediatric patients in a hospital setting, including the identification of significant organisms through various laboratory methods.
Year:
2012
Region / City:
UK
Topic:
Clinical microbiology, paediatric infections
Document Type:
Standard Operating Procedure (SOP)
Organization / Institution:
Health Protection Agency, UK
Author:
Not specified
Target Audience:
Medical professionals, laboratory staff
Period of validity:
Not specified
Approval Date:
December 2012
Date of Last Revision:
Not specified
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Note:
Year
Region / City:
Canberra
Subject:
Female Genital Cutting (FGC), Clinical Guidelines, Healthcare
Document Type:
Clinical Guideline
Organization / Institution:
Canberra Health Services
Target Audience:
Healthcare staff (medical officers, nurse practitioners, registered nurses, midwives, allied health, students)
Contextual Description:
Clinical guideline outlining the management and prevention of female genital cutting (FGC) for healthcare providers at Canberra Health Services.
Authors:
NHS Wales Safeguarding Network
Date:
28 August 2024
Version:
Final
Distribution:
NHS Wales (Intranet), Public Health Wales (Intranet)
Review Date:
August 2027
Work Plan Reference:
NHS Wales Safeguarding Network – Objective 3
Type of Document:
Clinical guidance
Target Audience:
NHS Wales professionals
Scope:
All Wales
Legislation Reference:
Serious Crime Act 2015
Author:
Dr R M Shah
Organisation:
Bordesley Green Surgery
Current Version Number:
2.1
Current Document Approved By:
Dr A.S Inguva
Date Approved:
04.05.2023
Next Review Date:
04.05.2024
Note:
Version History
Region:
United Kingdom
Topic:
Female Genital Mutilation (FGM)
Document Type:
Clinical Guidance
Institution:
Bordesley Green Surgery
Target Audience:
Healthcare professionals, NHS staff
Approval Date:
04.05.2023
Period of Application:
Until Next Review
Year:
2018
Region / city:
Austria
Subject:
Human rights violations, intersex genital mutilations, children
Document type:
NGO Report
Institution:
StopIGM.org / Zwischengeschlecht.org
Author:
Markus Bauer, Daniela Truffer
Target audience:
Human rights organizations, UN committees, healthcare professionals, policymakers
Effective period:
Ongoing
Approval date:
July 2018
Modification date:
Not specified
Year:
2016–2020
Country:
United Kingdom
Jurisdiction:
England and Wales
Topic:
Female Genital Mutilation
Document type:
Inter-agency protocol
Participating bodies:
National Police Chiefs’ Council; Crown Prosecution Service
Related legislation:
Female Genital Mutilation Act 2003; Serious Crime Act 2015
Policy context:
Ending Violence against Women and Girls Strategy
Subject scope:
Investigation, prosecution, and safeguarding in FGM cases
Intended users:
Police officers; CPS prosecutors
Protocol status:
Approved and authorised
Period of application:
Ongoing
Year:
2019
Region / City:
Kassala, White Nile, North Darfur
Topic:
Female Genital Mutilation (FGM), Child Early and Forced Marriage (CEFM)
Document Type:
Terms of Reference
Organization:
Plan International Sudan
Author:
Plan International Sudan
Target Audience:
Authorities, NGOs, researchers
Duration:
2 years (December 2019 – November 2021)
Approval Date:
December 2019
Date of Changes:
N/A
Year:
2023
Region:
Global
Subject:
Veterinary infectious diseases
Document type:
Scientific report
Organization:
World Organisation for Animal Health (OIE)
Authors:
International Committee on Animal Health Standards
Target audience:
Veterinary professionals, researchers, livestock farmers
Pathogen:
Campylobacter fetus subsp. venerealis and subsp. fetus
Transmission:
Natural mating, artificial insemination
Clinical signs:
Infertility, early embryonic death, abortion
Diagnostic methods:
Culture, immunofluorescence, ELISA, PCR, whole genome sequencing
Vaccine information:
Commercial and autologous vaccines available, limited evidence of efficacy
Laboratory precautions:
Biosafety and containment required for manipulations
Data sources:
Field sampling from bulls, cows, and aborted fetuses
Endemic regions:
Areas with reported bovine infertility and abortion outbreaks
Document type of source:
Veterinary disease guideline
Year:
2025
Location:
Geneva, Switzerland
Event:
61st session of the Human Rights Council
Theme:
Role of new and emerging digital technologies in preventing and eliminating female genital mutilation
Type:
High-level panel discussion
Organizer:
United Nations Human Rights Council
Chair:
H.E. Mr. Sidharto Reza Suryodipuro
Speakers:
Mr. Volker Türk, Ms. Mariya Taher, Ms. Catherine Russell, Ms. Diene Keita, Ms. Pernille Fenger, Dr. Pascale Allotey, Ms. Irene Kaggwa
Document type:
Concept note
Date of preparation:
20 February 2026
Venue:
Assembly Hall, Palais des Nations
Broadcast:
WebTV live and archived
Mandate:
Human Rights Council resolutions 16/21 and 59/16
Participants:
Member and observer States, UN agencies and funds, civil society, women and girls
Objective:
Discuss the role of digital technologies in preventing female genital mutilation and promoting gender equality
Outcome:
Summary report to be submitted at the 64th session of the Council
Subject:
Bovine genital campylobacteriosis
Disease:
Bovine genital campylobacteriosis
Causative agent:
Campylobacter fetus subsp. venerealis
Related subspecies:
Campylobacter fetus subsp. fetus; Campylobacter fetus subsp. testudinum
Animal species:
Cattle
Transmission:
Venereal transmission during natural mating and artificial insemination with infected semen
Clinical manifestations:
Infertility, early embryonic death, abortion
Reservoir:
Bulls
Diagnostic methods:
Culture, immunofluorescent antibody test (IFAT), monoclonal antibody capture ELISA, polymerase chain reaction, whole genome sequencing
Serological testing:
Antibody ELISA for herd immunity evaluation
Sample sources:
Preputial smegma, vaginal mucus, organs of aborted fetuses
Document type:
Veterinary disease reference chapter
Section:
Diagnostic techniques and taxonomy
Field:
Veterinary microbiology and animal health
Year:
Not specified
Jurisdiction:
Humboldt County, California, USA
Document type:
Certificate of Correction
Related law:
Subdivision Map Act Sections 66469, 66470; Professional Land Surveyors Act Section 8770.5
Prepared by:
Licensed Land Surveyor or Registered Civil Engineer
County official:
Robert W. Bronkall, LS 7645, County Surveyor
Intended use:
Correction of recorded parcel maps, tract maps, and records of survey
Filing location:
Office of the County Recorder, Humboldt County
References:
B&P Code Section 6731, GC Code Sections 66410–66470
Year:
2025
Region / city:
Victoria, Australia
Topic:
Health, Urinary Tract Infection, Pharmacist Services
Document type:
Patient handout
Author:
Department of Health, Victoria Government
Target audience:
Women and gender diverse people with female biology aged 18-65, including Medicare and international students
Period of validity:
December 2025
Approval date:
December 2025
Date of updates:
Not specified
Year:
2024
Region / City:
Wales
Topic:
Healthcare, Pharmacy, Urinary Tract Infection
Document Type:
Patient Group Directions (PGD)
Organisation:
Welsh Medicines Advice Service, NHS Wales
Author:
Dianne Burnett, Louise Allen, Emlyn Pritchard, Adam Mackridge, Richard Coulthard
Target Audience:
Healthcare professionals, community pharmacists
Validity Period:
From 03 June 2024 to 02 June 2027
Approval Date:
22 April 2024
Ratification Date:
09 May 2024
Review Date:
08 February 2027
Expiry Date:
02 June 2027
Version:
1.0
Change History:
Version 1.0 developed on 22 December 2023
Clinical Condition:
Acute, uncomplicated lower urinary tract infection
Treatment:
Nitrofurantoin, Trimethoprim
Applicable Group:
Non-pregnant females or transgender males (16-64 years)
Authorising Organisation:
Local Health Board
Staff Requirements:
Registered pharmacists, authorised by name
Retention Period:
8 years for adults, 25 years for children
Local Inquiries:
[insert local details]
Year:
2024
Region / city:
Victoria, Australia
Topic:
Urinary Tract Infection Treatment
Document Type:
Patient Handout
Organ / Institution:
Department of Health, Victoria
Author:
Department of Health, Victoria
Target Audience:
Women and gender diverse people with female biology aged 18-65
Period of validity:
March 2024
Approval date:
March 2024
Date of amendments:
N/A
Contextual Description:
Patient handout providing details about treatment, eligibility, and self-care for uncomplicated urinary tract infection under a pilot program for community pharmacists.
Note:
Year
Subject:
Healthcare Plan, Risk Management
Document Type:
Healthcare Plan
Target Audience:
Individuals at risk of urinary tract infections
Year:
2022
Region / city:
United Kingdom
Topic:
Healthcare, Infectious Diseases, Antimicrobial Resistance
Document Type:
Briefing Paper
Organization / Institution:
National Institute for Health and Care Excellence
Author:
NICE
Target Audience:
Healthcare professionals, Policy makers, Researchers
Period of validity:
Not specified
Approval Date:
12th July 2022
Date of Changes:
Not specified
Year:
1978
Region / City:
Larimer County, Colorado
Theme:
Real Estate, Property Development
Document Type:
Legal Declaration
Organization / Institution:
Not specified
Author:
Not specified
Target Audience:
Property developers, homebuilders, property owners
Period of validity:
Indefinite
Approval Date:
January 16, 1978
Date of Changes:
Not specified
Year:
2022
Region / city:
United Kingdom
Subject:
Health care, Medical guidelines
Document type:
Quality standard
Organization / institution:
National Institute for Health and Care Excellence (NICE)
Author:
National Institute for Health and Care Excellence (NICE)
Target audience:
Healthcare professionals, Service providers
Period of validity:
2022-2023
Approval date:
11 June 2015
Date of amendments:
6 September 2022
Note:
Contextual description
Version:
2.0
Year:
2025
Region / city:
[location/service/organisation]
Topic:
Urinary Tract Infection, Nitrofurantoin, PGD (Patient Group Direction)
Document type:
PGD (Patient Group Direction)
Organization:
UKHSA
Author:
Dr. Diane Ashiru-Oredope, Dr. Imran Jawaid, Dr. Kiren Collison, Dr. Naomi Fleming, Mandy Slatter, Jo Jenkins, Kieran Reynolds, Liz Cross, Professor Bhaskar Somani, Temitope Odetunde, Tracy Rogers
Target audience:
Registered healthcare professionals authorized by their organization
Effective date:
1st January 2026
Review date:
30th June 2028
Expiry date:
31st December 2028
Approval body:
UKHSA HCAI & AMR Division
Document version history:
1.0 (January 2023), 1.1 (July 2023), 1.2 (February 2024), 1.3 (April 2024), 1.4 (January 2025), 2.0 (October 2025)
PGD reviewed by:
National UTI antimicrobial PGD Short Life Working Group
Context:
This document outlines a Patient Group Direction for the use of nitrofurantoin in the treatment of urinary tract infections, specifying authorized practitioners and legal requirements.
Year:
2021
Region/Country:
United Arab Emirates
Type of document:
Clinical guideline
Organization:
National Antimicrobial Stewardship Committee
Target population:
Adult outpatients, Adult inpatients, Pregnant women
Scope:
Empiric antibiotic management of urinary tract infections
Version:
1
Date of issue:
1 September 2021
Review period:
Every three years
Attachments:
Risk factors for complicated UTIs, Summary tables for empiric treatment, National cumulative antibiogram 2019
References:
CDC, IDSA, ESCMID, FDA standards
Year:
Not specified
Region / City:
Not specified
Subject:
Acute uncomplicated urinary tract infection (UTI) treatment
Document Type:
Patient Group Direction (PGD)
Author:
Not specified
Target Audience:
Healthcare professionals, community pharmacy staff
Effective Period:
Not specified
Approval Date:
Not specified
Revision Date:
Not specified